Real-time enrollment status for this antibody-mediated rejection (amr) clinical trial
Current Status
Recruiting
Checked: November 9, 2026 at 8:53 PM UTC
| NCT Number | NCT07613359 |
| Recruiting Status | Recruiting |
| Condition | Antibody-Mediated Rejection (AMR) |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | November 6, 2026 (3 days ago) |
As of November 9, 2026: Clinical trial NCT07613359 is currently recruiting participants. This phase2 study for antibody-mediated rejection (amr) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07613359 is actively recruiting participants as of November 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07613359 was last updated 3 days ago (November 6, 2026). HelloStudys verifies this status automatically.